These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35204831)

  • 1. Optimization of an Inclusion Body-Based Production of the Influenza Virus Neuraminidase in
    Lipničanová S; Legerská B; Chmelová D; Ondrejovič M; Miertuš S
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of viral neuraminidase from inclusion bodies produced by recombinant Escherichia coli.
    Lipničanová S; Chmelová D; Godány A; Ondrejovič M; Miertuš S
    J Biotechnol; 2020 Jun; 316():27-34. PubMed ID: 32302655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.
    Joshi BH; Puri RK
    Protein Expr Purif; 2005 Feb; 39(2):189-98. PubMed ID: 15642470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level production of membrane proteins in E. coli BL21(DE3) by omitting the inducer IPTG.
    Zhang Z; Kuipers G; Niemiec Ł; Baumgarten T; Slotboom DJ; de Gier JW; Hjelm A
    Microb Cell Fact; 2015 Sep; 14():142. PubMed ID: 26377812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli.
    Isakova A; Artykov A; Vorontsova Y; Dolgikh D; Kirpichnikov M; Gasparian M; Yagolovich A
    Mol Biotechnol; 2023 Apr; 65(4):581-589. PubMed ID: 36094644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminolevulinate production with recombinant Escherichia coli using a rare codon optimizer host strain.
    Fu W; Lin J; Cen P
    Appl Microbiol Biotechnol; 2007 Jun; 75(4):777-82. PubMed ID: 17333171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway.
    Dvorak P; Chrast L; Nikel PI; Fedr R; Soucek K; Sedlackova M; Chaloupkova R; de Lorenzo V; Prokop Z; Damborsky J
    Microb Cell Fact; 2015 Dec; 14():201. PubMed ID: 26691337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification and characterization of low-glycosylation influenza neuraminidase in α-1,6-mannosyltransferase defective Pichia pastoris.
    Yang YL; Chang SH; Gong X; Wu J; Liu B
    Mol Biol Rep; 2012 Feb; 39(2):857-64. PubMed ID: 21567198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform.
    Hsieh SK; Yu YJ; Tang NY; Lin JR; Jinn TR
    Protein Pept Lett; 2017; 24(11):1021-1029. PubMed ID: 28741464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved conditions for production of recombinant plant sesquiterpene synthases in Escherichia coli.
    Picaud S; Olsson ME; Brodelius PE
    Protein Expr Purif; 2007 Jan; 51(1):71-9. PubMed ID: 16908191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Biomass Production of Recombinant Pfu DNA Polymerase Producer Escherichia coli BL21(DE3) by Optimization of Induction Variables Using Response Surface Methodology.
    Ceylan HK
    Protein J; 2023 Aug; 42(4):451-462. PubMed ID: 37199865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and characterization of inclusion bodies in recombinant Escherichia coli cells overproducing penicillin G acylase.
    Sriubolmas N; Panbangred W; Sriurairatana S; Meevootisom V
    Appl Microbiol Biotechnol; 1997 Apr; 47(4):373-8. PubMed ID: 9163951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of neuraminidase activity of influenza A virus subtype H5N1 and H1N1 using reverse genetics virus.
    Rawangkhan A; Sanguansermsri D; Suwannakhon N; Pongcharoen S; Pensuwan P; Chamnanpood C; Chamnanpood P; Sanguansermsri P
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):562-9. PubMed ID: 20578543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics.
    Dai M; Du W; Martínez-Romero C; Leenders T; Wennekes T; Rimmelzwaan GF; van Kuppeveld FJM; Fouchier RAM; Garcia-Sastre A; de Vries E; de Haan CAM
    mBio; 2021 May; 12(3):. PubMed ID: 33975931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015.
    Tewawong N; Vichiwattana P; Korkong S; Klinfueng S; Suntronwong N; Thongmee T; Theamboonlers A; Vongpunsawad S; Poovorawan Y
    PLoS One; 2017; 12(4):e0175655. PubMed ID: 28410396
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.
    Gao J; Klenow L; Parsons L; Malik T; Phue JN; Gao Z; Withers SG; Cipollo J; Daniels R; Wan H
    J Virol; 2021 Nov; 95(24):e0116021. PubMed ID: 34613807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coli.
    Tripathi NK; Priya R; Shrivastava A
    Appl Microbiol Biotechnol; 2014 Mar; 98(6):2461-71. PubMed ID: 24337252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses.
    Campbell PJ; Danzy S; Kyriakis CS; Deymier MJ; Lowen AC; Steel J
    J Virol; 2014 Apr; 88(7):3802-14. PubMed ID: 24429367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.